{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:13:31Z","timestamp":1792592011348,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.phrs.2023.106814","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T02:02:56Z","timestamp":1685757776000},"page":"106814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The burden of hypercholesterolemia and ischemic heart disease in an ageing world"],"prefix":"10.1016","volume":"193","author":[{"given":"Angela","family":"Pirillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Danilo","family":"Norata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2023.106814_bib1","series-title":"Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: institute for Health Metrics and Evaluation (IHME)","author":"Global Burden of Disease Collaborative Network","year":"2020"},{"issue":"6","key":"10.1016\/j.phrs.2023.106814_bib2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.117.311849","article-title":"Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease","volume":"121","author":"Leong","year":"2017","journal-title":"Circ. Res"},{"issue":"32","key":"10.1016\/j.phrs.2023.106814_bib3","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"10258","key":"10.1016\/j.phrs.2023.106814_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.phrs.2023.106814_bib5","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.phrs.2023.106814_bib6","first-page":"120","article-title":"Recent insights into low-density lipoprotein metabolism and therapy","volume":"24","author":"Pirillo","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"5","key":"10.1016\/j.phrs.2023.106814_bib7","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0000000000000330","article-title":"The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity","volume":"27","author":"Boren","year":"2016","journal-title":"Curr. Opin. Lipido"},{"issue":"24","key":"10.1016\/j.phrs.2023.106814_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"Jorgensen","year":"2013","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.phrs.2023.106814_bib9","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/eurheartj\/ehaa172","article-title":"Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study","volume":"41","author":"Kaltoft","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2023.106814_bib10","article-title":"Remnant cholesterol is associated with cardiovascular mortality","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.phrs.2023.106814_bib11","first-page":"412","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","author":"Emerging Risk Factors","year":"2009","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.phrs.2023.106814_bib12","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.phrs.2023.106814_bib13","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"New Engl. J. Med"},{"issue":"11","key":"10.1016\/j.phrs.2023.106814_bib14","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J. Lipid Res"},{"issue":"11","key":"10.1016\/j.phrs.2023.106814_bib15","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106814_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"10215","key":"10.1016\/j.phrs.2023.106814_bib17","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","article-title":"Cardiovascular Risk, Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium","volume":"394","author":"Brunner","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2023.106814_bib18","unstructured":"http:\/\/www.ncdrisc.org\/index.html."},{"key":"10.1016\/j.phrs.2023.106814_bib19","unstructured":"https:\/\/vizhub.healthdata.org\/gbd-compare\/."},{"issue":"16","key":"10.1016\/j.phrs.2023.106814_bib20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2019.11.072","article-title":"Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar","volume":"75","author":"Preiss","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106814_bib21","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.59946","article-title":"Health expenditure or cardiometabolic risk factors? A further explanation of the wide gap in cardiometabolic mortality between worldwide countries: an ecological study","volume":"16","author":"Lotfaliany","year":"2018","journal-title":"Int J. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2023.106814_bib22","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division (2022). World Population Prospects 2022, Online Edition."},{"key":"10.1016\/j.phrs.2023.106814_bib23","unstructured":"United Nations Department of Economic and Social Affairs, Population Division (2022). World Population Prospects 2022: Summary of Results. UN DESA\/POP\/2022\/TR\/NO. 3."},{"key":"10.1016\/j.phrs.2023.106814_bib24","unstructured":"https:\/\/data.worldbank.org\/indicator\/SH.XPD.CHEX.GD.ZS?locations=XD-XT-XN-XM."},{"key":"10.1016\/j.phrs.2023.106814_bib25","unstructured":"World Health Organization (WHO). Global spending on health: Weathering the storm; 2020."},{"issue":"9","key":"10.1016\/j.phrs.2023.106814_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061350","article-title":"Global, regional and national trends in statin utilisation in high-income and low\/middle-income countries, 2015-2020","volume":"12","author":"Guadamuz","year":"2022","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.phrs.2023.106814_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003841","article-title":"Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: a cross-sectional study of nationally representative surveys","volume":"18","author":"Marcus","year":"2021","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.phrs.2023.106814_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20010298","article-title":"Implementing and evaluating community health worker-led cardiovascular disease risk screening intervention in sub-saharan Africa communities: a participatory implementation research protocol","volume":"20","author":"Okop","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"10075","key":"10.1016\/j.phrs.2023.106814_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(16)32380-7","article-title":"Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women","volume":"389","author":"Stringhini","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2023.106814_bib30","doi-asserted-by":"crossref","DOI":"10.1530\/EC-21-0537","article-title":"Menopause-associated risk of cardiovascular disease","volume":"11","author":"Anagnostis","year":"2022","journal-title":"Endocr. Connect"},{"issue":"10355","key":"10.1016\/j.phrs.2023.106814_bib31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(22)01441-6","article-title":"Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study","volume":"400","author":"Walli-Attaei","year":"2022","journal-title":"Lancet"},{"issue":"9976","key":"10.1016\/j.phrs.2023.106814_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Cholesterol Treatment Trialists","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.phrs.2023.106814_bib33","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2014.02.615","article-title":"Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials","volume":"64","author":"Boekholdt","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2023.106814_bib34","unstructured":"I.D.F. Diabetes Atlas 2021, 10th edition https:\/\/diabetesatlas.org\/atlas\/tenth-edition\/."},{"issue":"5","key":"10.1016\/j.phrs.2023.106814_bib35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bluher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2023.106814_bib36","first-page":"73","article-title":"LDL-cholesterol-lowering therapy","volume":"270","author":"Pirillo","year":"2022","journal-title":"Handb. Exp. Pharm."},{"issue":"7810","key":"10.1016\/j.phrs.2023.106814_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-020-2338-1","article-title":"Factor Collaboration. Repositioning of the global epicentre of non-optimal cholesterol","volume":"582","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2023.106814_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/clinchem\/hvaa246","article-title":"Worldwide changes in total cholesterol and non-HDL-cholesterol trends indicate where the challenges are for the coming years","volume":"67","author":"Pirillo","year":"2021","journal-title":"Clin. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:37Z","timestamp":1760913817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"alternative-id":["S1043661823001706"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106814","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of hypercholesterolemia and ischemic heart disease in an ageing world","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106814"}}